Loading clinical trials...
Loading clinical trials...
This is a phase 1/2a study in dentin hypersensitivity patients to assess the safety, tolerability, efficacy and pharmacokinetics of single and multiple doses of KH001.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
HysensBio Co., Ltd
NCT07352956 · Dentin Sensitivity
NCT06378255 · Dentin Sensitivity
NCT06150573 · Dentin Sensitivity, Oral Hygiene
NCT06354270 · Dentin Sensitivity
NCT06802614 · Tooth Discoloration, Dentin Sensitivity, and more
Seoul National University Dental Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions